3–5 Sept 2024
Switzerland
Europe/Zurich timezone

A regulator perspective on clinical trials using new radionuclides

Not scheduled
20m
Paul Scherrer Institut (Switzerland)

Paul Scherrer Institut

Switzerland

Forschungsstrasse 111 5232 Villigen

Speaker

Dr Anna C. Senn (FOPH)

Presentation materials